Current Research
Combining Cell Lineages for Enhanced Joint Tissue
Regeneration
JA Wardale and
N Rushton
Support: Stryker
Stem cells for cartilage repair and
regeneration
N Hooper, JA Wardale, N Rushton
Support: John Insall
Foundation
Collagen scaffolds with aligned porosity
K Pawelec, JA Wardale, RE Cameron
Support: Gates
Foundation
Development of a smart implant for meniscus repair using
PRP-mediated biological repair
D Howard, N Rushton
Support:
NIHR i4i
Modulating the response of impaction loading to articular
cartilage
P
Hernandez-Valdez, FMD Henson, N Rushton
Support:
Merck KGaA
The augmentation of microfracture with
rhFGF18
FMD Henson, J Power, AM Getgood, N
Rushton
Support: Merck
KGaA
Artificial ligament with bioactive
nanostructure
Z Ahmad, RA Brooks, JA Wardale, N
Rushton
Support:
EPSRC
Skeletal site variation in bone cell
behaviour
RA Brooks, N Loveridge, N Rushton
Support: NIHR Biomedical
Research Centre
In vitro investigation
of plasma sprayed zinc substituted
hydroxyapatite
DV Shepherd, RA Brooks, SM
Best
Support:
Orthopaedic Research U
K
Atomic Level Structure of Extracellular
Matrix
RA Brooks, R Rajan, D Reid, J Skepper, MJ
Duer
Support: BBSRC
Early glycation products of collagen: a solid-state NMR
spectroscopy and ultrastructural study of biological and health
implications
RA Brooks, R Rajan, D Reid, J Skepper MJ
Duer
Support:
MRC
Academic-Industrial Initial Training Network on Innovative
Biocompatible Titanium-based Structures for Orthopaedics
(BioTiNet)
RA Brooks, M Golozar, L Greer, SM Best
Support: EU
FP7
Actuation of Ferromagnetic Fibre Networks to improve Implant
Longevity (AFFINITY)
RA Brooks, V Malheiro, R Spear, A
Markaki
Support: EU FP7
ALBiON Project (click here for more
details)
Zafar Ahmad, John
Wardale, Roger Brooks, Davide Enea, Fran Henson, Neil Rushton
Support: TSB and EPSRC
The TSB funded project
"ALBioN - Artificial Ligament with Bioactive Nanostructure (OM-DTI
LigaMimetic Proj)" was aimed at investigating the application of a
smart, nanocomposite material based on collagen and glycosaminoglycans the
regenerative repair of torn ligaments. It would build on an existing novel
biomaterials-based technology to develop a medical device product that is
both compatible with existing surgical techniques and capable of improving
clinical outcomes. The proposed project was intended to produce an early
prototype of this device and test it in a large-animal model. The four
partners in this consortium were a world-leading centre for biomaterials
research; a renowned institution for preclinical and clinical orthopaedic
research; a leading manufacturer of medical-grade collagen; and an SME
focussed on the development of novel products for the regenerative repair of
articular joint injuries.
Please click here to
see our main ALBiON page for more details.
|
